A detailed history of Bollard Group LLC transactions in Danaher Corp stock. As of the latest transaction made, Bollard Group LLC holds 8,292 shares of DHR stock, worth $2.04 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,292
Previous 8,288 0.05%
Holding current value
$2.04 Million
Previous $1.92 Million 8.03%
% of portfolio
0.06%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $898 - $1,024
4 Added 0.05%
8,292 $2.07 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $64,785 - $81,595
350 Added 4.41%
8,288 $1.92 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $979,868 - $1.12 Million
4,204 Added 112.59%
7,938 $1.97 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $13,274 - $15,112
59 Added 1.61%
3,734 $896,000
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $959 - $1,108
4 Added 0.11%
3,675 $926,000
Q4 2022

Feb 10, 2023

BUY
$241.42 - $282.29 $724 - $846
3 Added 0.08%
3,671 $974,000
Q3 2022

Nov 09, 2022

BUY
$247.06 - $1507.4 $988 - $6,029
4 Added 0.11%
3,668 $947,000
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $711 - $898
3 Added 0.08%
3,664 $929,000
Q1 2022

May 12, 2022

BUY
$257.27 - $315.76 $771 - $947
3 Added 0.08%
3,661 $1.07 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $584 - $658
2 Added 0.05%
3,658 $1.2 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $816 - $997
3 Added 0.08%
3,656 $1.11 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $675 - $815
3 Added 0.08%
3,653 $980,000
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $469,754 - $645,429
3,650 New
3,650 $645,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $179B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.